Laboratory identification and sensitivity testing of yeast isolates

References

• Reingold A L, Lu X D, Plikaytis B D, Ajello L. Systemic mycosis in the United States 1980–1982. J Med Vet Mycol 1986; 24: 433–6
   PubMedGoogle Scholar
• Harvey R L, Myers J P. Nosocomial fungemia in a large community teaching hospital. Arch Intern Med 1987; 147: 2117–20
   PubMedGoogle Scholar
• Komshian S V, Uwaydah A K, Sobel J D, Crane L R. Fungemia caused by Candida species and Torulopsis glabrata in the hospital patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989; 11: 379–90
   PubMedGoogle Scholar
• Anaissie E, Bodey G P, Kantarjian H. New spectrum of fungal infections in patients with cancer. Rev Infect Dis 1989; 11: 369–78
   PubMedGoogle Scholar
• Land G A, Salkin I F. Uncommon yeastlike zoo-pathogens and commercial systems for their identification. Mycopathologia 1987; 99: 155–71
   PubMedGoogle Scholar
• Hadfield T L, Smith M B, Winn R E, Rinaldi M G, Guerra C. Mycoses caused by Candida lusitaniae. Rev Infect Dis 1987; 9: 1006–12
   PubMedGoogle Scholar
• Haley D L, Trandel J, Coyle M B. Cumitech 11, practical methods for the culture and identification of fungi in the clinical microbiology laboratory. American Society for Microbiology, Washington, DC 1980
   Google Scholar
• Odds F C. Candida and candidosis. A review and bibliography. Baillière Tindall, London 1988
   Google Scholar
• Cooper B H, Silva-Hutner M. Yeasts of medical importance. Manual of clinical microbiology, E H Lenette, A Balows, W J Hausler, H J Shadomy. American Society for Microbiology, Washington, DC 1985; 526–41
   Google Scholar
• Roberts G D. Laboratory diagnosis of fungal infections. Hum Pathol 1976; 7: 161–8
   PubMedGoogle Scholar
• Pincus D H, Salkin I F, Hurd N J, Levy I L, Kemna M A. Modification of potassium nitrate assimilation test for identification of clinically important yeasts. J Clin Microbiol 1988; 26: 366–8
   PubMedGoogle Scholar
• Zimmer B I, Roberts G D. Rapid selective urease test for presumptive identification of Cryptococcus neoformans. J Clin Microbiol 1979; 10: 380–1
   PubMed Web of Science ®Google Scholar
• Staib F. Cryptococcus neoformans and Guizotia abyssinica (syn. G. oleifera DC.) (Farbreaktion fur C. neoformans). Z. Hyg Infektionskr Med Microbiol Immunol Virol 1962; 148: 466–75
   Google Scholar
• Hopfer R L, Blank F. Caffeic acid-containing medium for identification of Cryptococcus neoformans. J Clin Microbiol 1975; 2: 115–20
   Google Scholar
• Braunstein H. Quality control in microbiology: a review and bibliography. Clin Lab Med 1986; 6: 649–74
   PubMedGoogle Scholar
• Buesching W J, Kurek K, Roberts G D. Evaluation of the modified API 20C system for identification of clinically important yeasts. J Clin Microbiol 1979; 9: 565–9
   PubMed Web of Science ®Google Scholar
• Salkin I F, Land G A, Hurd N J, Goldson P R, McGinnis M R. Evaluation of Yeast Ident and Uni-Yeast-Tek yeast identification systems. J Clin Microbiol 1987; 25: 624–7
   PubMedGoogle Scholar
• Pfaller M A, Preston T, Bale M, Koontz F P, Body B A. Comparison of the Quantum II, API Yeast Ident, and AutoMicrobic systems for identification of clinical yeast isolates. J Clin Microbiol 1988; 26: 2054–8
   PubMedGoogle Scholar
• Medoff G, Kobayashi G A. The polyenes. Antifungal chemotherapy, DCE Speller. John Wiley & Sons, Chichester 1980; 3–33
   Google Scholar
• Blinkhorn R J, Adelstein D, Spagnuolo P J. Emergence of a new opportunistic pathogen, Candida tusitaniae. J Clin Microbiol 1989; 27: 236–40
   PubMed Web of Science ®Google Scholar
• Pappagianis D, Collins M S, Hector R, Remington J. Development of resistance to amphotericin B in Candida lusilaniae infecting a human. Antimicrob Agents Chemother 1979; 16: 123–6
   PubMed Web of Science ®Google Scholar
• Dick J D, Merz W G, Saral R. Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother 1980; 18: 158–63
   PubMed Web of Science ®Google Scholar
• Powderly W G, Kobayashi G S, Herzig G P, Medoff G. Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med 1988; 84: 826–32
   PubMed Web of Science ®Google Scholar
• Scholer H J. Flucytosine. Antifungal chemotherapy, DCE Speller. John Wiley & Sons, Chichester 1980; 36–106
   Google Scholar
• Kobayashi G S, Spitzer. Testing of organisms for susceptibility to triazoles: is it justified. Eur J Clin Microbiol Infect Dis 1989; 8: 387–9
   PubMedGoogle Scholar
• Galgiani J N, Reiser J, Brass C, Espinel-Ingroff A, Gordon M A, Kerkering T M. Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods. Antimicrob Agents Chemother 1987; 31: 1343–7
   PubMedGoogle Scholar
• Shadomy S, White S C, Yu H P, Dismukes W E. Treatment of systemic mycosis with ketoconazole: in vitro susceptibilities of clinical isolates of systemic and pathogenic fungi to ketoconazole. J Infect Dis 1985; 152: 1249–56
   PubMed Web of Science ®Google Scholar
• Shadomy S, Espinel-Ingroff A, Cartwright R Y. Laboratory studies with antifungal agents: susceptibility tests and bioassays. Manual of clinical microbiology, E H Lenette, A Balows, W J Hausler, H J Shadomy. American Society for Microbiology, Washington, DC 1985; 991–9
   Google Scholar
• Galgiani J N, Stevens D A. Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent on inoculum size. Antimicrob Agents Chemother 1976; 10: 721–6
   PubMedGoogle Scholar
• Odds F C, Abbott A B. Relative inhibition factors—a novel approach to the assessment of antifungal antibiotics in vitro. J Antimicrob Chemother 1984; 13: 31–43
   PubMedGoogle Scholar
• Calhoun D L, Roberts G D, Galgiani J N. Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosin and amphotericin B. J Clin Microbiol 1986; 23: 298–301
   PubMed Web of Science ®Google Scholar
• Drutz D J. In vitro antifungal susceptibility testing and measurement of levels of antifungal agents in body fluids. Rev Infect Dis 1987; 9: 392–7
   PubMedGoogle Scholar
• British Society for Mycopathology. Report of a Working Group. Laboratory methods for flucytosine (5-fluorocytosine). J Antimicrob Chemother 1984; 14: 1–8
   Google Scholar
• Polak A. Multicenter study on the standardization of sensitivity testing of fungi against 5-fiuorocytosine and amphotericin B. Mykosen 1987; 30: 306–14
   PubMedGoogle Scholar
• National Committee for Clinical Laboratory Standards. Antifungal susceptibility testing; Committee Report. NCCLS publ. no. M20-CR. NCCLS, Villanova, Pa 1985
   Google Scholar
• Dermoumi H. Eine Anleitung zur Resistenzbestimmung bei Antimykotika. Mycoses 1988; 31: 532
   PubMedGoogle Scholar
• Casals J B. Tablet sensitivity testing of pathogenic fungi. J Clin Pathol 1979; 32: 719–22
   PubMed Web of Science ®Google Scholar
• Casals J B, Pringler N. Antimicrobial sensitivity testing using neo-sensitabs. Rosco Diagnostica, TaastrupDenmark 1987; 42–3
   Google Scholar